Segment, Customer and Geographical Reporting (Tables)

12 Months Ended

Sep. 30, 2015

The Company’s segment information is summarized below:

Results of Operations for the Fiscal Year Ended September 30,
2015
	Contract
	Research			Optics			Instruments		Biomedical		Total
Revenue	$	18,753,000		$	21,783,000		$	-	$	-	$	40,536,000
Gross Profit		8,176,000			7,076,000			-		-		15,252,000
GM %		43.6	%		32.5	%		-		-		37.6	%
SG&A		7,629,000			6,516,000			-		1,151,000		15,296,000
Gain on sale of assets		-			178,000			-		-		178,000
Operating Income (Loss)		547,000			738,000			-		(1,151,000)		134,000

Depreciation and Amortization		296,000			839,000			-		61,000		1,196,000
Capital expenditures		18,000			1,166,000			-		119,000		1,303,000

Intangibles, Net		264,000			678,000			-		283,000		1,225,000
Goodwill		4,939,000			1,192,000			-		-		6,131,000
Total Assets	$	7,692,000		$	15,948,000		$	48,000	$	828,000	$	24,516,000

Results of Operations for the Fiscal Year Ended September 30,
2014
	Contract
	Research			Optics			Instruments			Biomedical			Total
Revenue	$	21,935,000		$	19,590,000		$	773,000		$	11,000		$	42,309,000
Gross Profit		9,301,000			7,100,000			318,000			11,000			16,730,000
GM %		42.4	%		36.2	%		41.1	%		100.0	%		39.5	%
SG&A		8,546,000			5,482,000			527,000			778,000			15,333,000
Gain on sale of assets		-			-			1,297,000			-			1,297,000
Operating Income (Loss)		755,000			1,618,000			1,087,000			(765,000)			2,695,000

Depreciation and Amortization		280,000			781,000			2,000			60,000			1,123,000
Capital expenditures		12,000			1,326,000			-			110,000			1,448,000

Intangibles, Net		299,000			854,000			-			230,000			1,383,000
Goodwill		4,939,000			1,308,000			-			-			6,247,000
Total Assets	$	8,857,000		$	16,019,000		$	313,000		$	1,188,000		$	26,377,000

Revenues by geographic location in total and as a percentage of total revenue, for the years ended September 30, 2015 and 2014 are as follows: